FDA Proposes Changes To Advisory Committee Voting Procedures
This article was originally published in The Gray Sheet
Executive Summary
FDA is proposing that members of its advisory committees vote on issues simultaneously, rather than sequentially, to avoid influencing each other
You may also be interested in...
US FDA Advisory Committee Formats Can Spur Unhealthy Dynamics – Califf
FDA commissioner is thinking about how advisory panel interactions might improperly influence meeting outcomes as the agency undertakes a 'stem to stern' review of the process.
Study Supports FDA Advisory Committee Conflict-Of-Interest Waivers
Constructing FDA advisory committees free from any conflicts of interest would be expensive and time-consuming and would likely exclude many of the most highly qualified candidates, according to an analysis commissioned by the agency
Study Supports FDA Advisory Committee Conflict-Of-Interest Waivers
Constructing FDA advisory committees free from any conflicts of interest would be expensive and time-consuming and would likely exclude many of the most highly qualified candidates, according to an analysis commissioned by the agency